ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,385,000 | +13.4% | 179,500 | -29.2% | 0.00% | 0.0% |
| Q2 2019 | $2,984,000 | +62.8% | 253,550 | +88.9% | 0.00% | +100.0% |
| Q1 2019 | $1,833,000 | +1597.2% | 134,250 | +1178.6% | 0.00% | – |
| Q4 2018 | $108,000 | -78.4% | 10,500 | -65.0% | 0.00% | -100.0% |
| Q3 2018 | $500,000 | +216.5% | 30,000 | +200.0% | 0.00% | – |
| Q2 2018 | $158,000 | -66.7% | 10,000 | -31.0% | 0.00% | -100.0% |
| Q3 2016 | $475,000 | -4.8% | 14,500 | -27.5% | 0.00% | 0.0% |
| Q2 2016 | $499,000 | -16.1% | 20,000 | +11.1% | 0.00% | 0.0% |
| Q4 2015 | $595,000 | -43.8% | 18,000 | -10.0% | 0.00% | 0.0% |
| Q2 2015 | $1,059,000 | +62.2% | 20,000 | -10.9% | 0.00% | 0.0% |
| Q4 2014 | $653,000 | – | 22,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |